Filing Details
- Accession Number:
- 0001213900-21-049820
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-24 17:00:49
- Reporting Period:
- 2021-09-22
- Accepted Time:
- 2021-09-24 17:00:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1553643 | Relmada Therapeutics Inc. | RLMD | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1117167 | J Charles Casamento | C/O Relmada Therapeutics, Inc. 2222 Ponce De Leon Blvd, 3Rd Floor Coral Gables, FL 33134 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-22 | 10,000 | $4.60 | 16,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-22 | 1,900 | $29.00 | 14,700 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-22 | 3,300 | $29.00 | 11,400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-22 | 1,400 | $29.00 | 10,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Disposition | 2021-09-22 | 1,900 | $0.00 | 1,900 | $3.24 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 97,311 | 2017-10-20 | 2027-10-20 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
- The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period..
- Not applicable
Billionaire Hedge Funds
